Evaluation of efficacy of Topical Timolol for treatment in conjunctival Pyogenic Granulom

Phase 2

Recruiting

• Conditions: Pyogenic granuloma.; Pyogenic granuloma; L98.0

• Registration Number: IRCT20160523028008N27
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 46

Inclusion Criteria

Pyogenic granuloma
Consent to participate in the study

Exclusion Criteria

Pregnancy
Presence of previous similar lesions
Lost of follow-up after 6 week.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
esion healing. Timepoint: 6 weeks after treatment. Method of measurement: Eye examination.;Recurrence of the lesion. Timepoint: 6 weeks after treatment. Method of measurement: Eye examination.

Secondary Outcome Measures

Name	Time	Method
Complication. Timepoint: 12 weeks after treatment. Method of measurement: Eye examination.